News

Corporate Governance

The Board of Directors of Cerulean Pharma Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate, in the best interests of the Company, or as required by applicable laws and regulations.


Committee Composition
  Audit Nominating and Governance Compensation
William H. Rastetter, Ph.D.
William H. Rastetter, Ph.D.
Lead Independent Director
   
Stuart A. Arbuckle
Stuart A. Arbuckle
Director
 
Paul A. Friedman, M.D.
Paul A. Friedman, M.D.
Executive Chairman
   
William T. McKee
William T. McKee
Director
 
David R. Parkinson, M.D.
David R. Parkinson, M.D.
Director
   
David R. Walt Ph.D.
David R. Walt Ph.D.
Director
 
= Chair = Member

Corporate Governance Documents
Title View
AUDIT COMMITTEE CHARTER
COMPENSATION COMMITTEE CHARTER
NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER
AMENDED AND RESTATED CORPORATE GOVERNANCE GUIDELINES
CODE OF BUSINESS CONDUCT AND ETHICS
= add file to Briefcase
Shareholder Tools